pH-Reduction dual responsive nanocarriers (DRNs) achieve programmable release of CA4 and CDDP in cancer therapy.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: